Detact Diagnostics
Delfzijl
About Detact Diagnostics
Detact holds the patent for a new, innovative, real-time, bacterial detection system that enables hospital staff to determine bacterial presence on surface areas with an easy to use system: the b-Swab.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.2M
- Last round: Grant (Nov 2025)
- Website: detactdiagnostics.com
- Phone: +310615382382
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/detact-diagnostics-158333 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.